Latest
Beyond biologics: Amgen bets new drugs will pay dividend
Amgen executives believe the biotech giant will grow substantially in the next decade, pursuing drugs that treat major melanoma and bone loss.
Latest
ValueClick defies its skeptics
ValueClick is out to prove to investors that it still has some pluck after more than a decade in the digital marketing business.
Latest
UCSB engineering recruits Bell Labs veteran
UC Santa Barbara has named a new dean of its College of Engineering.
Latest
Pouring in millions: Japanese food oil venture proposed for harbor area
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
